Literature DB >> 16814206

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.

Guglielmo Ronco1, Paolo Giorgi-Rossi, Francesca Carozzi, Paolo Dalla Palma, Annarosa Del Mistro, Laura De Marco, Margherita De Lillo, Carlo Naldoni, Paola Pierotti, Raffaella Rizzolo, Nereo Segnan, Patrizia Schincaglia, Manuel Zorzi, Massimo Confortini, Jack Cuzick.   

Abstract

BACKGROUND: Testing for human papillomavirus (HPV) DNA is more sensitive but less specific than cytological analysis. Loss in specificity is most relevant in women younger than 35 years because of increased HPV prevalence. We aimed to compare conventional screening with an experimental strategy in women aged 25-34 years, and investigate the effect of different criteria of referral to define the best methods of HPV screening.
METHODS: Women were randomly assigned to the conventional procedure (standard cytology, with referral to colposcopy if cytology showed atypical squamous cells of undetermined significance or more [ASCUS+]) or an experimental procedure (liquid-based cytology and testing for high-risk HPV types, with referral to colposcopy with ASCUS+ cytology). Women positive for HPV (cutoff > or = 1 pg/mL) but with normal cytology were retested after 1 year. The main endpoint was the presence of cervical intraepithelial neoplasia at grade 2 or more (CIN2+) in reviewed histology. The main analysis was by intention to screen. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN81678807.
FINDINGS: We randomly assigned 5808 women aged 25-34 years to the conventional group and 6002 to the experimental group. The experimental procedure was significantly more sensitive than the conventional procedure (55 vs 33 CIN2+ lesions detected; relative sensitivity 1.61 [95% CI 1.05-2.48]), but had a lower positive predictive value (PPV; relative PPV 0.55 [0.37-0.82]). HPV testing (> or = 1 pg/mL) with cytology triage was also more sensitive than conventional cytology (relative sensitivity 1.58 [1.03-2.44], relative PPV 0.78 [0.52-1.16]). Relative PPV could be improved, with minimum loss in sensitivity, by use of a 2 pg/mL cutoff for HPV testing. Compared with conventional cytology, liquid-based cytology had a relative sensitivity of 1.32 (0.84-2.06), relative PPV 0.58 [0.38-0.89]).
INTERPRETATION: HPV testing alone with cytology triage could be a feasible alternative to conventional cytology for screening women younger than 35 years. Follow-up will provide data on possible overdiagnosis and on the feasibility of extended intervals.

Entities:  

Mesh:

Year:  2006        PMID: 16814206     DOI: 10.1016/S1470-2045(06)70731-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  43 in total

1.  Pharyngeal squamous cell papilloma in adult Japanese: comparison with laryngeal papilloma in clinical manifestations and HPV infection.

Authors:  Ryoji Hirai; Kiyoshi Makiyama; Yusho Higuti; Atsuo Ikeda; Masatoshi Miura; Hisashi Hasegawa; Noriko Kinukawa; Minoru Ikeda
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-04       Impact factor: 2.503

2.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

3.  Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.

Authors:  Philip E Castle; Patti E Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

Review 4.  Primary HPV screening for cervical cancer prevention: results from European trials.

Authors:  Elsebeth Lynge; Matejka Rebolj
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

5.  Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment.

Authors:  Massimo Confortini; Francesca Carozzi; Marco Zappa; Leonardo Ventura; Anna Iossa; Paola Cariaggi; Livia Brandigi; Mario Franchini; Francesco Mirri; Paolo Viacava; Aurora Scarfantoni; Daniela Bazzanti; Cristina Sani
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

6.  Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.

Authors:  D C Rijkaart; V M H Coupe; F J van Kemenade; D A M Heideman; A T Hesselink; W Verweij; L Rozendaal; R H Verheijen; P J Snijders; J Berkhof; C J L M Meijer
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

7.  Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening.

Authors:  M Rebolj; E Lynge
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

8.  Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.

Authors:  Paolo Giorgi Rossi; Simonetta Bisanzi; Irene Paganini; Angela Di Iasi; Claudio Angeloni; Aurora Scalisi; Rosalba Macis; Maria Teresa Pini; Francesco Chini; Francesca Maria Carozzi
Journal:  BMC Infect Dis       Date:  2010-07-20       Impact factor: 3.090

Review 9.  New paradigms in cervical cancer prevention: opportunities and risks.

Authors:  Guglielmo Ronco; Paolo Giorgi Rossi
Journal:  BMC Womens Health       Date:  2008-12-17       Impact factor: 2.809

10.  Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.

Authors:  Luisa Barzon; Colomba Giorgi; Franco M Buonaguro; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2008-12-16       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.